NOVT vs CGNX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NOVT · Novanta$101.99 ▼ 11.22%
CGNX · Cognex$44.36 ▼ 6.92%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NOVT +5.6%
- CGNX +28.9%
Head to head
| Metric | NOVT | CGNX |
|---|---|---|
| Price | $101.99 | $44.36 |
| Change today | ▼ 11.22% | ▼ 6.92% |
| Market cap | $3.86B | $7.47B |
| Return, 3 months | -26.9% | -26.7% |
| Return, year to date | -14.3% | +23.8% |
| Return, 1 year | -4.2% | +27.8% |
| P/E (TTM) | 77.3 | 31.0 |
| P/B | 2.4 | 4.3 |
| P/E percentile vs own 5y | 68th | 10th |
| Dividend yield | – | 0.77% |
| Revenue growth (YoY, latest qtr) | +23.1% | +13.2% |
| Net profit growth (YoY) | -81.1% | +380.2% |
| Gross margin | 44.5% | 69.7% |
| Operating margin | 11.8% | 25.0% |
| Net margin | 4.9% | 21.5% |
| Return on equity | 4.4% | 15.1% |
| Analyst target vs. price | +71.6% | +60.2% |
| Analyst buy share | 100% | 69% |
| RSI (14) | 29 | 36 |
| 30-day volatility | 79.3% | 60.6% |
| Max drawdown, 1 year | -39.6% | -34.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CGNX is the largest of the group by market value.
- CGNX has returned the most over the past year.
- CGNX carries the lowest trailing P/E.
- NOVT is growing revenue fastest.
- CGNX keeps the most profit per dollar of sales.
- CGNX has been the calmest stock over the last 30 days.